The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma.

Paris A, Tardif N, Baietti FM, Berra C, Leclair HM, Leucci E, Galibert MD, Corre S
EMBO Mol Med. 2022 Dec 7;14(12):e15677. doi: 10.15252/emmm.202215677. Epub 2022 Oct 28. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.